Trial
NCT01314066
Efficacy of Bevacizumab in Preventing Acute Respiratory Distress Syndrome (ARDS)
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Weill Medical College of Cornell University
Collaborators
—
Condition
Severe Sepsis
Intervention
Bevacizumab
Why stopped
No funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-05-03